Skip to content

LV Kinesitherapie

Active
Private limited companyfounded 2021active for 5 yearsWilde Heide 1, 3150 Haacht, BelgiumKBO/BCE: BE 0776.455.801
Summary

LV Kinesitherapie has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €33,598 and a net result of €31,598. Equity is growing by about 66% per year across the filed financial years. Its solvency ranks better than 20% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Physiotherapy
NACE 86951
1 site
Size
€166,544total assets 2025
Equity
€33,598
Profit
€31,598
Turnover not published (micro format)
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 18 days early1 deed in the Belgian Official Gazette
Why 91lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.87, cash €65,788Figures for financial year 2025 (filed 13-07-2026)Size: total assets €166,544Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 27% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 45-55
equity 20.2% of total assets
Liquidity 56-44
short-term debt 79.8% · cash 39.5%
Profitability 92-8
return on assets 19.0%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,126 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value
Credit of up to €3,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.87, compared with 32.23 in 2024, below 1; short-term debt: 79.8% and cash: 39.5% of total assets), and 79.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 20% on solvency, 31% on liquidity, 50% on profitability and 8% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.87, cash €65,788
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 13-07-2026)
NBB · annual accounts
lowers risk · Size: total assets €166,544
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 20620 sector peers (2025).
NBB · sector comparison
Position among 20620 sector peers
Solvency
better than 20%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
18 days early
2024
13 days early
2023
7 days early
2022
31 days early
2021
27 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 19 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
28-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Liquidity more than 7 timescurrent ratio 32.23

Key points

  • Caution: Equity fell in 2025from €149,772 to €33,598 ▼ 77.6% View
  • Caution: Among the weakest 20% on solvencysector median 63.0% · 20,620 companies 20.2% View
  • Positive: Always filed on timeaccounts within the deadline every year 5 years View
  • Positive: 5 profitable years in a rowprofit 2025: €31,598 5 years View

By topic

Financials

Financial year
2025
Total assets
€166,544
Profit
€31,598
Solvency
20.2%
Total assets▲ 8.1%
Net result
20212025
Go to Financials

Timeline

Events
9
Since
2022
Next accounts
by 31-07-2027
  1. 24-07-2024Annual accounts filed
  2. 31-12-2023Equity above €100,000
  3. 30-06-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
PhysiotherapyNACE 86951
Founded
25-10-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about LV Kinesitherapie

What is the company number of LV Kinesitherapie?
0776.455.801. In Belgium the VAT number is the company number with BE in front: BE 0776.455.801.
Where is LV Kinesitherapie based?
The registered office is at Wilde Heide 1, 3150 Haacht.Company details
What does LV Kinesitherapie do?
According to the KBO register, the main activity is physiotherapy (NACE 86951).
What is the legal form of LV Kinesitherapie?
Private limited company (BV).
When was LV Kinesitherapie founded?
On 25-10-2021.
Is LV Kinesitherapie still active?
Yes, LV Kinesitherapie is an active enterprise in the KBO register.
What is the turnover of LV Kinesitherapie?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is LV Kinesitherapie profitable?
In financial year 2025, LV Kinesitherapie made a profit of €31,598.
Where can I find the annual accounts of LV Kinesitherapie?
LV Kinesitherapie filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of LV Kinesitherapie due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to LV Kinesitherapie

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.